Immunovia being noted on Nasdaq Stockholm on April 3, 2018

Immunovia being noted on Nasdaq Stockholm on April 3, 2018

Here you can find press releases, news, prospectus, presentations and financial reports about Immunovia AB. Additionally, we have included information about the share, the owners, insider trading, calendar and financial situation.

If you have further questions, please contact our IR contact.

If you are interested to receive our press releases and reports, please click on “Subscribe”.

The Immunovia AB share is since 3 April 2018 traded on Nasdaq Stockholm. Immunovia has one class of shares. The Company has a registered share capital of SEK 1,131,579.05 allocated among 22,631,581 shares. The par value of the shares is SEK 0.05 per share.

Trading information
Ticker on Nasdaq Stockholm: IMMNOV
ISIN-code: SE0006091997
LEI-code: 549300KHWL6KK1XGUO81
The shares are registered by the Euroclear Sweden.



Link to financial reports

Shareholder Newsletters

Shareholder Newsletter, Q4 2016 (PDF in English)

Nyhetsbrev till aktieägare, Q4 2016 (PDF in Swedish)


CEO summarizes year 2015 in this first shareholder newsletter.

Shareholder Newsletter (PDF in English)

Nyhetsbrev till aktieägare (PDF in Swedish)


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports